Figure 6

Therapeutic effects of MHP1-AcN after transient middle cerebral artery occlusion. (A) Infarction volume at 48 h after ischemia. MHP1-AcN began 6 or 8 h post-ischemia at various doses. (B) Temporal changes of neurological severity score after ischemic stroke. **P < 0.01, *P < 0.05 vs saline-treated mice.